RUSSO, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 2.373
AS - Asia 2.138
EU - Europa 1.643
AF - Africa 121
SA - Sud America 104
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.384
Nazione #
US - Stati Uniti d'America 2.349
VN - Vietnam 622
SG - Singapore 585
CN - Cina 498
GB - Regno Unito 424
SE - Svezia 234
DE - Germania 206
IT - Italia 185
HK - Hong Kong 154
FR - Francia 129
IN - India 115
RU - Federazione Russa 87
BR - Brasile 70
IE - Irlanda 67
UA - Ucraina 66
NL - Olanda 58
ZA - Sudafrica 45
CH - Svizzera 42
JP - Giappone 38
EE - Estonia 37
TG - Togo 36
FI - Finlandia 29
BE - Belgio 21
PH - Filippine 19
NG - Nigeria 18
BG - Bulgaria 16
AR - Argentina 14
JO - Giordania 14
KR - Corea 13
CA - Canada 12
CI - Costa d'Avorio 12
GR - Grecia 11
MX - Messico 10
ID - Indonesia 9
IQ - Iraq 9
TR - Turchia 9
BD - Bangladesh 8
IR - Iran 8
TH - Thailandia 8
ES - Italia 7
PL - Polonia 7
AT - Austria 6
SA - Arabia Saudita 6
SC - Seychelles 6
TW - Taiwan 6
MY - Malesia 5
EC - Ecuador 4
PE - Perù 4
CO - Colombia 3
LB - Libano 3
PY - Paraguay 3
UZ - Uzbekistan 3
AU - Australia 2
BO - Bolivia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
EU - Europa 2
KZ - Kazakistan 2
MK - Macedonia 2
PK - Pakistan 2
RS - Serbia 2
AL - Albania 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 6.384
Città #
Singapore 410
Southend 384
Ashburn 278
Fairfield 239
Chandler 220
Hong Kong 145
Ho Chi Minh City 135
San Jose 116
Woodbridge 113
Dong Ket 108
Hanoi 107
Houston 100
Seattle 97
Beijing 96
Wilmington 93
Santa Clara 92
Ann Arbor 90
Princeton 83
Dublin 67
Cambridge 65
Boardman 49
Nanjing 43
Lauterbourg 41
New York 40
Westminster 39
Bern 37
Tokyo 37
Lomé 36
Padova 36
Jacksonville 35
Haiphong 30
Los Angeles 27
Bologna 26
Helsinki 26
Medford 26
Hefei 25
Saint Petersburg 24
Da Nang 23
Brussels 21
Buffalo 19
Jinan 19
Turin 19
Frankfurt am Main 18
Abeokuta 16
Milan 16
Sofia 16
Hyderabad 15
Shanghai 15
Shenyang 15
Amman 13
Berlin 13
Changsha 13
Hebei 13
Abidjan 12
Guangzhou 12
Norwalk 12
Bremen 11
Dallas 11
San Diego 11
São Paulo 11
Chicago 10
Munich 10
Orem 10
Redwood City 10
Johannesburg 9
Mülheim 9
Olalla 9
Redondo Beach 9
Florence 8
Jiaxing 8
Nanchang 8
Seoul 8
Tianjin 8
Dearborn 7
London 7
Mountain View 7
Xi'an 7
Baghdad 6
Bangkok 6
Hangzhou 6
Thái Bình 6
Torino 6
Biên Hòa 5
Brooklyn 5
Manila 5
Phoenix 5
Taizhou 5
Thái Nguyên 5
Council Bluffs 4
Dammam 4
Falls Church 4
Farra d'Isonzo 4
Foshan 4
Fremont 4
Fuzhou 4
Istanbul 4
Jakarta 4
Kunming 4
Mahé 4
Montreal 4
Totale 4.211
Nome #
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 233
ARF Loss, a Negative Prognostic Factor in Philadelphia-Positive Acute Lymphoblastic Leukemia, May Be Efficiently Overcome by the Small Molecule MDM2 Antagonist RG7112 226
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib 213
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis 209
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) 209
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: A new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients 207
Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation 195
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 188
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 188
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients 187
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 184
Feed supplemented with three different antibiotics improved food intake and reduced the activation of the humoral immune response in healthy weaned pigs but had differing effects on intestinal microbiota 182
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 182
Backtracking BCR-ABL1 Mutants in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Relapsing on Tyrosine Kinase Inhibitors with Deep Sequencing: Implications for Routine Mutation Testing 179
Effect of different butyrate supplementations on growth and health of weaning pigs challenged or not with E. coli K88 174
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia 172
Expression of High-Molecular-Mass Neurofilament Protein in Horse (Equus caballus) Spinal Ganglion Neurons. 171
Intrinsic neuronal control of the pyloric sphincter of the lamb. 167
Distribution pattern and Chemical coding of sympathetic trunk ganglia neurons supplying the boar urinary bladder trigone 166
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 165
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease 161
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 159
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 157
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 157
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications 156
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 154
Distribution pattern and chemical coding of sympathetic trunk ganglia neurons supplying the boar urinary bladder trigone. 148
Neurochemical features of boar lumbosacral dorsal root ganglion neurons and characterization of sensory neurons innervating the urinary bladder trigone 148
Intrinsic innervation of the ileocaecal junction in the horse: Preliminary study 147
Intrinsic innervation of the horse ileum 145
Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy 138
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology 138
Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies 125
Innervazione delle tonsille palatine nella pecora 120
Innervation of palatine tonsils in sheep (ovis aries) 119
Innervazione delle tonsille palatine nella pecora. 117
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain 117
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 109
You have accessClinical Relevance of Low Burden BCR-ABL1 Mutations Detectable By Amplicon Deep Sequencing (DS) in Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients (pts): The Type of Mutation Matters 97
Intrisic and extrinsic innervation of the ileocecal junction in the horse. 79
Totale 6.488
Categoria #
all - tutte 17.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 25 22 188
2021/2022727 45 17 40 74 78 44 14 49 35 64 132 135
2022/2023869 95 128 31 127 60 64 24 60 140 15 70 55
2023/2024198 9 43 6 18 16 57 10 7 10 6 2 14
2024/2025850 49 158 84 49 138 25 57 21 8 82 18 161
2025/20261.858 144 122 137 123 221 123 239 77 536 136 0 0
Totale 6.488